$17.41
-1.59-8.37%
Last update: Oct 30, 4:00 PM

Greenwich LifeSciences (GLSI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.33 | $-0.35 | $-0.32 | $-0.32 |
| Actual | $-0.27 | $-0.39 | $-0.58 | $-0.30 |
| Surprise | +18.2% | -11.4% | -81.3% | +6.25% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.33 | $-0.34 | $-0.29 |
| Revenue | |||
| Consensus | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.27 | $-0.33 | 18.2 % |
| Q1 | Jun 3, 2026 | $-0.39 | $-0.35 | -11.4 % |
| Q4 | Jun 1, 2026 | $-0.58 | $-0.32 | -81.3 % |
| Q3 | Nov 14, 2025 | $-0.30 | $-0.32 | 6.25 % |